Navigation Links
Tigris Pharmaceuticals Initiates Phase I Study of AFP-464 in Patients with Solid Tumors
Date:1/30/2008

st cancer.

About Tigris Pharmaceuticals, Inc.

Tigris Pharmaceuticals, Inc. is a privately held biopharmaceutical company that develops therapeutic technologies to treat oncology, infectious diseases and other areas of unmet medical need. Tigris is currently conducting a Phase II clinical study for A-007, its topical treatment for pre-cancerous and cancerous anogenital lesions associated with HPV. Tigris is also developing three novel, targeted small molecule oncology compounds. Tigris' mission is to efficiently move its existing and future technologies through the various stages of clinical development in order to meet patients' needs for safe and effective treatments of human illnesses.

Contact:

Anne White

Chief Operating Officer

Tigris Pharmaceuticals, Inc.

(239) 444-5400

info@tigrispharma.com

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are valid only as of today, and we disclaim any obligation to update this information. These statements are subject to known and unknown risks and uncertainties that may cause actual future experience and results to differ materially from the statements made. These statements are based on our current beliefs and expectations as to such future outcomes. Drug discovery and development involve a high degree of risk. Factors that might cause such a material difference include, among others, uncertainties related to the ability to attract and retain partners for our technologies, the identification of lead compounds, the successful preclinical development thereof, the completion of clinical trials, the FDA review process and other governmental regulation, our pharmaceutical collaborator's ability to successfully develop and commercialize drug candidates, competition from other pharmaceutical companies, product pricing and third par
'/>"/>

SOURCE Tigris Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Peregrine Pharmaceuticals Opens Enrollment in Phase II Clinical Trial of Bavituximab in Patients with Advanced Breast Cancer
2. Poniard Pharmaceuticals Announces Picoplatin Safety Data in Colorectal Cancer
3. Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
4. Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
5. Cogentus Pharmaceuticals Begins Clinical Study to Confirm the Full Antiplatelet Benefit of New Combination Medicine CGT-2168
6. Cerimon Pharmaceuticals Initiates Phase II/III Clinical Studies to Evaluate its Diclofenac Patch for Mild to Moderate Pain
7. Morria Biopharmaceuticals Plc Announces Preliminary Safety and Tolerability Results From Its Phase I Clinical Study of MRX-4 in Allergic Rhinitis Patients
8. First Patient Enrolled in Cogentus Pharmaceuticals Pivotal Phase 3 Trial of Novel Combination Medicine
9. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
10. Vion Pharmaceuticals Announces FDA Lift of Clinical Hold on Phase III Study of Cloretazine(R) (VNP40101M) and Cytarabine in Relapsed AML
11. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013 More than ... may not benefit from chemotherapy and still have excellent ... launch of one of the largest sources of online ... website and interactive Facebook page provide recently diagnosed women ... can safely avoid chemotherapy. "We anticipate these ...
(Date:5/23/2013)... , May 23, 2013  Hologic, Inc. (Hologic ... a leading developer, manufacturer and supplier of premium ... an emphasis on serving the healthcare needs of ... study in a U.S. clinical practice comparing breast ... tomosynthesis) with conventional 2D mammography alone showed a ...
(Date:5/23/2013)... 2013  BioElectronics Corporation (OTC Pink: BIEL), the maker ... the FDA panel meeting for non-thermal shortwave diathermy: ... Shortwave Therapy Meeting was held on May 21, 2013 ... focus of the meeting was very narrow, in that ... on the application of non-thermal shortwave diathermy for the ...
Breaking Medicine Technology:Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 3First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 2First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 3First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 4BioElectronics and Pulsed Shortwave Therapy Make Progress 2
... 2012 /PRNewswire-Asia/ -- Winner Medical Group Inc. (Nasdaq: ... China-based exporter and retailer of high-quality medical dressings and ... financial results for the first quarter of fiscal 2012, ... Quarter of Fiscal 2012 Financial Highlights , ...
... Inc. (Nasdaq: ANTH ), a biopharmaceutical company ... will release its fourth quarter 2011 financial report before ... will host a conference call at 1 pm Eastern ... also provide an update for both the varespladib and ...
Cached Medicine Technology:Winner Medical Reports First Quarter of Fiscal 2012 Results 2Winner Medical Reports First Quarter of Fiscal 2012 Results 3Winner Medical Reports First Quarter of Fiscal 2012 Results 4Winner Medical Reports First Quarter of Fiscal 2012 Results 5Winner Medical Reports First Quarter of Fiscal 2012 Results 6Winner Medical Reports First Quarter of Fiscal 2012 Results 7Winner Medical Reports First Quarter of Fiscal 2012 Results 8Winner Medical Reports First Quarter of Fiscal 2012 Results 9Winner Medical Reports First Quarter of Fiscal 2012 Results 10Winner Medical Reports First Quarter of Fiscal 2012 Results 11Winner Medical Reports First Quarter of Fiscal 2012 Results 12Winner Medical Reports First Quarter of Fiscal 2012 Results 13Winner Medical Reports First Quarter of Fiscal 2012 Results 14Winner Medical Reports First Quarter of Fiscal 2012 Results 15Winner Medical Reports First Quarter of Fiscal 2012 Results 16Winner Medical Reports First Quarter of Fiscal 2012 Results 17Winner Medical Reports First Quarter of Fiscal 2012 Results 18Anthera Announces Fourth Quarter 2011 Financial Report and Conference Call 2
(Date:5/25/2013)... (HealthDay News) -- Animals make great companions for senior citizens, ... the car are far more likely to crash than those ... The new study included 2,000 licensed drivers aged 70 and ... how often they drove with their pet in the car. ... crash risk was twice as high as among those who ...
(Date:5/25/2013)... 2013 Absolute Surgical Specialists, serving Sun City ... NALA’s businesses throughout the country participating in Shop Local for ... the nationwide event as he understands what military families go ... Army. He said, “I wanted to give something back, as ... I live here too.” , Shop Local for a Cause ...
(Date:5/25/2013)... On May 25, Voices Against Brain ... advocacy, comments on a new study by the Max ... atmospheric plasma into brain cancer treatment may help when ... Science Daily article, physicists from the Max ... demonstrated the “synergistic effect of cold atmospheric plasma -- ...
(Date:5/25/2013)... 2013 Acuity Games ’ innovative brain ... of Word Hunt is available today, expanding it ... Match, Flash 2, Sudoku and Matchematics will roll out over ... and revolutionary lifetime brain fitness measurement have been re-optimized for ... years of brain fitness measurement in your pocket. What ...
(Date:5/25/2013)... Ayurveda is the traditional medicine of India. ... a medical science, its scope enters into the realms of ... is that disease is the end result of living out ... health, one must discover where we are living out of ... back into perfect harmony. , The Foundations course in Mexico ...
Breaking Medicine News(10 mins):Health News:Seniors More Likely to Crash When Driving With Pet: Study 2Health News:Dr. Craig Amshel of Absolute Surgical Specialists Offering Bowel Prep During the Shop Local for a Cause Event 2Health News:Voices Against Brain Cancer Comments on Study that Shows Cold Plasma’s Success Against Brain Cancer Cells 2Health News:Acuity Games Apps Come to the iPhone 2Health News:Fundamentos de Ayurveda in Mexico (Ayurvedic Principles) Offered by Escuela de Ayurveda de California 2
... peanut butter as salmonella probe widens; Kellog recalls Famous ... sickened, 6 dead, in 43 states and Canada , , ... and Drug Administration on Saturday warned consumers not to ... butter paste, as the investigation into the widespread salmonella ...
... Company,today announced a voluntary recall of certain Austin(R) ... snack-size packs of Famous Amos(R),Peanut Butter Cookies and ... products have the potential to be contaminated with,Salmonella. ... , (Photo: http://www.newscom.com/cgi-bin/prnh/20090116/CLF082 ...
... the condition, study says , , FRIDAY, Jan. 16 (HealthDay ... doctors detect some forms of autism, potentially leading to ... researchers say. , Scientists will need to confirm the ... looked at just 27 people with autism. Follow-up research ...
... N.Y., Jan. 16 KJT Group announces a former Harris ... KJT Group is pleased to announce the appointment of ... A resident of Rochester, Mr. Moller has a BA ... Science in Public Policy Analysis from the University of ...
... that often goes untreated , , FRIDAY, Jan. 16 (HealthDay ... in correctional facilities across the country suffer a much ... general population does, a new report finds. ... the total U.S. population -- also have difficulty accessing ...
... AMERIGROUP Foundation announced today that it is honoring Kim ... Academy, by designating her a "Healthy Hero."Ms. Bearden is ... Clark Academy, a nonprofit school that serves financially vulnerable ... the past two decades, she has won numerous educational ...
Cached Medicine News:Health News:FDA Warns Consumers Not to Eat Peanut Butter Products 2Health News:FDA Warns Consumers Not to Eat Peanut Butter Products 3Health News:FDA Warns Consumers Not to Eat Peanut Butter Products 4Health News:Kellogg Company Announces Voluntary Nationwide Recall of Austin(R) and Keebler(R) Branded Peanut Butter Sandwich Crackers and Select Snack-Size Packs of Famous Amos(R) and Keebler(R) Soft Batch Peanut Butter Cookies Because of Possible Health Risk 2Health News:Kellogg Company Announces Voluntary Nationwide Recall of Austin(R) and Keebler(R) Branded Peanut Butter Sandwich Crackers and Select Snack-Size Packs of Famous Amos(R) and Keebler(R) Soft Batch Peanut Butter Cookies Because of Possible Health Risk 3Health News:Saliva Test Could Indicate Autism 2Health News:KJT Group L.L.C. Continues Solid Growth 2Health News:Many in U.S. Prisons Lack Good Health Care 2Health News:Many in U.S. Prisons Lack Good Health Care 3Health News:Atlanta Educator Kim Bearden Honored as 'Healthy Hero' by AMERIGROUP Foundation 2
... pro Electronic Pipette is ideal for all ... easy-to-follow display, ergonomically-placed operating buttons, and various ... pipetting and diluting make this a lab ... of a manual pipette without any adverse ...
... provide a complete hematology profile, including a ... aggregation. Aggregation testing is based on performing ... platelet activation, using either collagen or ADP ... and no special sample preparation is required. ...
... A complete range of automatic systems for ... 1 mL of blood. With the introduction ... the clinical diagnostic market a truly revolutionary ... technical limitation associated with the traditional ESR ...
... range of automatic systems for performing erythrocyte ... of blood. With the introduction of the ... diagnostic market a truly revolutionary testing system ... associated with the traditional ESR techique.,By means ...
Medicine Products: